PROFILE1014_2A: PROFILE1014, figure 2A

PROFILE1014_2AR Documentation

PROFILE1014, figure 2A

Description

Kaplan-Meier digitized data from PROFILE1014, figure 2A (PMID 27022118). A reported sample size of 343 for a primary endpoint of PFS in lung cancer.

Usage

PROFILE1014_2A

Format

A data frame of 343 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (chemo, crizotinib)

Source

Solomon BJ, Cappuzzo F, Felip E, et al. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014. J Clin Oncol 2016; 34: 2858-67.

Examples

summary(PROFILE1014_2A)

kmplot(PROFILE1014_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.